TBPH- Theravance Biopharma, Inc.
Theravance Biopharma, Inc. (TBPH) has 11 insiders with recent SEC Form 4 filings, including 2 buys and 9 sells. TBPH is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.65M | $27.37M | - | |
| VP | 355.3K | $5.89M | - | |
| CFO | 336.8K | $5.58M | - | |
| VP | 242.4K | $4.02M | -13,314 | |
| VP | 201.0K | $3.33M | - |
Activity
Buys and sells only
Transactions
10 filings · page 2
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2024 | Farnum Rhonda52 | SVP, Comm &Medical Affairs | Sell | 4,000 | $9.00 | $36,000.00 | -1.2% | -10.1% | +29.9% | |
| May 1, 2024 | Samaha Eli58 | 10% Owner | Buy | 1,499,124 | $8.75 | $13,117,335.00 | +10.0% | +13.8% | +17.5% | |
| Feb 22, 2024 | Farnum Rhonda52 | SVP, Comm &Medical Affairs | Sell | 1,254 | $8.71 | $10,922.34 | -0.4% | +3.5% | +7.4% | |
| Nov 21, 2023 | Farnum Rhonda52 | SVP, Comm &Medical Affairs | Sell | 1,378 | $10.29 | $14,179.62 | -0.4% | -13.2% | -3.0% | |
| Nov 14, 2023 | Graham Richard A71 | SVP, Research &Development | Sell | 2,482 | $10.22 | $25,366.04 | -0.7% | -16.7% | -6.0% | |
| Oct 16, 2023 | Graham Richard A71 | SVP, Research &Development | Sell | 2,482 | $9.03 | $22,412.46 | -0.7% | +6.3% | -5.1% | |
| Sep 14, 2023 | Graham Richard A71 | SVP, Research &Development | Sell | 2,482 | $9.89 | $24,546.98 | -0.7% | +13.4% | -16.2% | |
| Aug 22, 2023 | Farnum Rhonda52 | SVP, Comm &Medical Affairs | Sell | 1,807 | $9.47 | $17,112.29 | -0.5% | +9.9% | -14.8% | |
| Aug 11, 2023 | Graham Richard A71 | SVP, Research &Development | Sell | 2,322 | $9.99 | $23,196.78 | -0.7% | +1.0% | -23.2% | |
| Jul 14, 2023 | Graham Richard A71 | SVP, Research &Development | Sell | 2,322 | $9.84 | $22,848.48 | -0.7% | -6.2% | -4.3% |